Literature DB >> 8125144

Modulation of the transcripts for tumor necrosis factor-alpha and its receptors in vivo.

S de Kossodo1, B Critico, G E Grau.   

Abstract

We investigated the effects of a single bacterial lipopolysaccharide (LPS) injection in vivo on the gene expression of tumor necrosis factor-alpha (TNF) and its receptors: TNF receptor type I (TNF-R 55 kDa or TNF-R1) and TNF receptor type II (TNF-R 75 kDa or TNF-R2) in various tissues and white blood cells. While TNF mRNA rapidly accumulated in most tissues, TNF-R1 and TNF-R2 mRNA levels were found to be differentially regulated in lung, spleen, lymph nodes and white blood cells. In most cases, TNF-R mRNA levels did not parallel TNF mRNA levels. These observations indicate that TNF-R of both types of capable of modulating the host response to LPS, not only by shedding of their extracellular domains, but also by strict regulation of their gene expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125144     DOI: 10.1002/eji.1830240342

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid.

Authors:  D J Conway; M J Holland; R L Bailey; A E Campbell; O S Mahdi; R Jennings; E Mbena; D C Mabey
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 2.  The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Authors:  G Kollias; E Douni; G Kassiotis; D Kontoyiannis
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

3.  Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes.

Authors:  Sun Ju Choi; Kyoung-Ho Lee; Hyun Sook Park; Soo-Ki Kim; Choon-Myung Koh; Joo Young Park
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

4.  CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN.

Authors:  Diana Legarda; Scott J Justus; Rosalind L Ang; Nimisha Rikhi; Wenjing Li; Thomas M Moran; Jianke Zhang; Emiko Mizoguchi; Matija Zelic; Michelle A Kelliher; J Magarian Blander; Adrian T Ting
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.